York Bridge Wealth Partners, LLC Ionis Pharmaceuticals Inc Transaction History

York Bridge Wealth Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$59.06 - $72.15 $90,184 - $110,173	-1,527 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$62.09 - $86.14 $6,581 - $9,130	106 Added 7.46%	1,527 $98,000
Q1 2019 May 09, 2019	SELL	$52.92 - $81.17 $2,116 - $3,246	-40 Reduced 2.74%	1,421 $115,000
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $4,888 - $6,121	-114 Reduced 7.24%	1,461 $73,000
Q2 2018 Aug 10, 2018	BUY	$40.53 - $50.7 $1,378 - $1,723	34 Added 2.21%	1,575 $66,000
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $1,454 - $1,816	-33 Reduced 2.1%	1,541 $68,000
Q4 2017 Feb 12, 2018	SELL	$50.3 - $64.39 $15,794 - $20,218	-314 Reduced 16.63%	1,574 $77,000
Q3 2017 Oct 27, 2017	SELL	$45.56 - $59.57 $6,515 - $8,518	-143 Reduced 7.04%	1,888 $96,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,031	2,031 $106,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.